arrow
K

Katia Todoerti

irccs aou san martino ist
H指数:42
被引数:4,658

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

曲美木单抗和度伐利尤单抗作为微卫星不稳定性高、可切除的胃或胃食管结合部腺癌患者的新辅助治疗或非手术治疗策略:GONO开展的INFINITY研究

2025-03-018
PRE
Specific dynamic changes of peripheral blood immune profile (PBIP) associate with clinical response to nivolumab (NIVO) in patients (pts) with metastatic renal cell carcinoma (mRCC): The I-RENE trial (meet-URO 8)
2023-10-011
OAAI
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents

CD38-Induced代谢功能障碍为多发性骨髓瘤细胞提供降低NAD的药物

2023-02-157
OAAI
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells

MiR-146b-5p调节慢性淋巴细胞白血病细胞中IL-23受体复合物的表达

2022-10-138
OAAI
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins

长链非编码RNA NEAT1的激活通过支持DNA修复蛋白的正调控环而导致多发性骨髓瘤细胞的生存优势

2022-09-0813
OAAI
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment
2021-10-219
OAAI
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs

多发性骨髓瘤中线粒体质量控制基因的表观遗传调控: HMCLs的Sequenom MassARRAY初步研究

2021-03-216
OAAI
Amino acid depletion triggered by.-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death

-天冬酰胺酶引发的氨基酸耗竭通过诱导线粒体ROS介导的细胞死亡使MM细胞对卡非佐米敏感

2020-09-1120
OAAI
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs
2019-11-079
OAAI
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma
LEUKEMIA
IF13.4
2019-08-1987
PREAI